Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Kohn

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|August 1, 1993
Unrelated donor BMT for Wiskott-Aldrich syndromeC Lenarsky, K Weinberg, D B Kohn, et al.
Immunology Today|October 8, 2014
The treatment of adenosine deaminase deficiencyR M Blaese, D B Kohn, R C Moen
Blood|July 1, 1995
Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cellsJ A Nolta, E M Smogorzewska, D B Kohn
Seminars in Hematology|November 4, 1998
Hematopoietic stem cell transplantation for primary lymphoid immunodeficienciesN Kapoor, G Crooks, D B Kohn, et al.
Cancer Investigation|January 1, 1989
Gene therapy for genetic diseasesD B Kohn, W F Anderson, R M Blaese
Physiological Chemistry and Physics|January 1, 1979
The role of inert particles in malignant transformations: a hypothesis of carcinogenesisB Ecanow, B H Gold, D B Kohn, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1987
Immunologic studies of lymph node lymphocytes in the generalized lymphadenopathy syndromeD B Kohn, M E Trigg, W Borcherding, et al.
Hematology/Oncology Clinics of North America|June 1, 1990
Bone marrow transplantation for genetic diseasesC Lenarsky, D B Kohn, K I Weinberg, et al.
Antisense & Nucleic Acid Drug Development|January 1, 1996
Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibitionC Zhou, I Bahner, J J Rossi, et al.
The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Expression of coagulation factor IX (Christmas factor) in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transferE M Gordon, H Tang, R L Salazar, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|August 1, 1993
Unrelated donor BMT for Wiskott-Aldrich syndromeC Lenarsky, K Weinberg, D B Kohn, et al.
Immunology Today|October 8, 2014
The treatment of adenosine deaminase deficiencyR M Blaese, D B Kohn, R C Moen
Blood|July 1, 1995
Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cellsJ A Nolta, E M Smogorzewska, D B Kohn
Seminars in Hematology|November 4, 1998
Hematopoietic stem cell transplantation for primary lymphoid immunodeficienciesN Kapoor, G Crooks, D B Kohn, et al.
Cancer Investigation|January 1, 1989
Gene therapy for genetic diseasesD B Kohn, W F Anderson, R M Blaese
Physiological Chemistry and Physics|January 1, 1979
The role of inert particles in malignant transformations: a hypothesis of carcinogenesisB Ecanow, B H Gold, D B Kohn, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1987
Immunologic studies of lymph node lymphocytes in the generalized lymphadenopathy syndromeD B Kohn, M E Trigg, W Borcherding, et al.
Hematology/Oncology Clinics of North America|June 1, 1990
Bone marrow transplantation for genetic diseasesC Lenarsky, D B Kohn, K I Weinberg, et al.
Antisense & Nucleic Acid Drug Development|January 1, 1996
Expression of hammerhead ribozymes by retroviral vectors to inhibit HIV-1 replication: comparison of RNA levels and viral inhibitionC Zhou, I Bahner, J J Rossi, et al.
The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Expression of coagulation factor IX (Christmas factor) in human hepatoma (HepG2) cell cultures after retroviral vector-mediated transferE M Gordon, H Tang, R L Salazar, et al.
Pageof 12